Plains GP (PAGP) Scheduled to Post Earnings on Friday

Plains GP (NYSE:PAGPGet Free Report) is set to post its quarterly earnings results before the market opens on Friday, May 3rd. Analysts expect Plains GP to post earnings of $0.53 per share for the quarter. Persons interested in participating in the company’s earnings conference call can do so using this link.

Plains GP (NYSE:PAGPGet Free Report) last announced its earnings results on Friday, February 9th. The pipeline company reported $0.27 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.06). The business had revenue of $12.70 billion for the quarter, compared to analysts’ expectations of $12.88 billion. Plains GP had a net margin of 0.41% and a return on equity of 1.33%. On average, analysts expect Plains GP to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Plains GP Stock Down 0.5 %

Shares of NYSE PAGP opened at $18.92 on Friday. The firm’s 50-day moving average price is $17.97 and its 200-day moving average price is $16.70. The company has a current ratio of 0.98, a quick ratio of 0.87 and a debt-to-equity ratio of 0.49. The stock has a market capitalization of $3.73 billion, a price-to-earnings ratio of 18.55 and a beta of 1.55. Plains GP has a 12-month low of $12.59 and a 12-month high of $19.77.

Plains GP Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Wednesday, May 1st will be given a dividend of $0.3175 per share. This represents a $1.27 annualized dividend and a dividend yield of 6.71%. The ex-dividend date of this dividend is Tuesday, April 30th. Plains GP’s dividend payout ratio is 124.51%.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the stock. Stifel Nicolaus increased their price objective on shares of Plains GP from $18.00 to $22.00 and gave the stock a “buy” rating in a research report on Tuesday, April 16th. UBS Group increased their price objective on shares of Plains GP from $22.00 to $23.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Barclays increased their price objective on shares of Plains GP from $16.00 to $18.00 and gave the stock an “underweight” rating in a research report on Friday, April 12th. The Goldman Sachs Group increased their price objective on shares of Plains GP from $14.50 to $16.00 and gave the stock a “sell” rating in a research report on Friday, April 12th. Finally, StockNews.com raised shares of Plains GP from a “hold” rating to a “buy” rating in a research note on Monday, March 4th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $19.55.

Check Out Our Latest Report on Plains GP

Plains GP Company Profile

(Get Free Report)

Plains GP Holdings, L.P., through its subsidiary, Plains All American Pipeline, L.P., owns and operates midstream infrastructure systems in the United States and Canada. It operates in two segments, Crude Oil and Natural Gas Liquids (NGLs). The company engages in the gathering and transporting crude oil and NGLs using pipelines, gathering systems, and trucks.

Read More

Earnings History for Plains GP (NYSE:PAGP)

Receive News & Ratings for Plains GP Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plains GP and related companies with MarketBeat.com's FREE daily email newsletter.